1. Current insulinization trends in India.
- Author
-
Hasnani, Dhruvi, Saboo, Bharat, Chaturvedi, Ashutosh, Sikdar, Mahuya, Shankar, Arun, Choudhury, Rupam, Saboo, Banshi, Singh, Nishtha Manish, Jha, Santosh, and Chavda, Vipul
- Subjects
INSULIN therapy ,ORAL drug administration ,GLYCEMIC control ,ATTITUDES of medical personnel ,HYPOGLYCEMIC agents ,DRUG resistance ,TYPE 2 diabetes ,SURVEYS ,DATA analysis software ,DISEASE management ,DISEASE complications - Abstract
Background: Hyperglycemia-associated micro- and macro-vascular complications remain the leading cause of premature morbidity and mortality among the diabetic population worldwide. Poor glycemic control due to clinical inertia towards insulin treatment is a major cause behind the development of diabetic complications. In this paper, we analyze different strategies of insulin treatment initialization and titration practiced in India. Methods: The response of 367 healthcare professionals (HCPs) across the country was recorded based on a survey on demographics, treatment regimens, and patient behavior. For analysis, the responses from HCPs were segregated into six regions, north, south, east, west, and central, covering the entire country. Results: The survey revealed that 59.1% HCPs preferred using three oral anti-diabetic drugs (OADs) before starting insulin therapy while 12.5% initiated insulin as the last option after trying all available OADs. Besides, 61% HCPs across India considered initiating insulin in type 2 diabetes mellitus (T2DM) patients when the patients (i) failed to achieve glycemic targets with current OADs, or (ii) could not tolerate OADs, or (iii) required a more flexible therapy. In T2DM patients, 52.9% HCPs chose basal only insulin during initiation. In comparison, 63.8% HCPs used basal bolus while initiating insulin in type 1 DM (T1DM) patients. Pan-India, 53.4% HCPs preferred analogue premix while 46.6% HCPs opted for human premix. Next, 98.9% HCPs counselled patients about the risk of hypoglycemia upon initiation of insulin. Conclusion: This survey outlines an urgent need of reducing the clinical inertia against insulin initialization in Indian settings. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF